CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Common Stock Restricted Stock Units	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive (Loss)/Income	Non-Controlling Interest in Consolidated Subsidiaries
Balance, beginning of period (in shares) at Dec. 31, 2023		57,787
Balance, beginning of period at Dec. 31, 2023	$ 3,471,470	$ 58		$ 1,008,766	$ 2,501,107	$ (39,040)	$ 579
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock units vested (in shares)			261
Equity withheld for employee taxes (in shares)		(88)
Equity withheld for employee taxes	(26,012)			(26,012)
Stock-based compensation expense	41,642			41,642
Exercise of stock options (in shares)		369
Exercise of stock options	15,251			15,251
Repurchase of common stock, including excise tax (in shares)		(396)
Repurchase of common stock, including excise tax	(120,593)				(120,593)
Other comprehensive income (loss)	(22,316)					(22,312)	(4)
Net income	116,243				116,243
Balance, end of period (in shares) at Mar. 31, 2024		57,933
Balance, end of period at Mar. 31, 2024	3,475,685	$ 58		1,039,647	2,496,757	(61,352)	575
Balance, beginning of period (in shares) at Dec. 31, 2023		57,787
Balance, beginning of period at Dec. 31, 2023	3,471,470	$ 58		1,008,766	2,501,107	(39,040)	579
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	351,234
Balance, end of period (in shares) at Sep. 30, 2024		56,708
Balance, end of period at Sep. 30, 2024	3,554,629	$ 57		1,129,238	2,465,269	(40,517)	582
Balance, beginning of period (in shares) at Mar. 31, 2024		57,933
Balance, beginning of period at Mar. 31, 2024	3,475,685	$ 58		1,039,647	2,496,757	(61,352)	575
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock units vested (in shares)			69
Equity withheld for employee taxes (in shares)		(18)
Equity withheld for employee taxes	(4,577)			(4,577)
Stock-based compensation expense	35,285			35,285
Exercise of stock options (in shares)		23
Exercise of stock options	1,339			1,339
Issuance of common stock from employee stock purchase plan (in shares)		85
Issuance of common stock from employee stock purchase plan	15,717			15,717
Repurchase of common stock, including excise tax (in shares)		(1,160)
Repurchase of common stock, including excise tax	(216,071)	$ (1)			(216,070)
Contributions to consolidated subsidiary from noncontrolling interest	7						7
Other comprehensive income (loss)	(8,071)					(8,071)
Net income	98,645				98,645
Balance, end of period (in shares) at Jun. 30, 2024		56,932
Balance, end of period at Jun. 30, 2024	3,397,959	$ 57		1,087,411	2,379,332	(69,423)	582
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock units vested (in shares)			7
Equity withheld for employee taxes (in shares)		(3)
Equity withheld for employee taxes	(611)			(611)
Stock-based compensation expense	41,136			41,136
Exercise of stock options (in shares)		17
Exercise of stock options	1,302			1,302
Repurchase of common stock, including excise tax (in shares)		(245)
Repurchase of common stock, including excise tax	(50,409)				(50,409)
Other comprehensive income (loss)	28,906					28,906
Net income	136,346				136,346
Balance, end of period (in shares) at Sep. 30, 2024		56,708
Balance, end of period at Sep. 30, 2024	$ 3,554,629	$ 57		1,129,238	2,465,269	(40,517)	582
Balance, beginning of period (in shares) at Dec. 31, 2024	56,869	56,869
Balance, beginning of period at Dec. 31, 2024	$ 3,631,151	$ 57		1,190,222	2,555,796	(116,864)	1,940
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock units vested (in shares)			315
Equity withheld for employee taxes (in shares)		(117)
Equity withheld for employee taxes	(21,455)			(21,455)
Stock issued in connection with Other 2021 acquisitions (in shares)		2
Stock issued in connection with Other 2021 acquisitions	375			375
Stock-based compensation expense	46,885			46,885
Exercise of stock options (in shares)		353
Exercise of stock options	19,448			19,448
Repurchase of common stock, including excise tax (in shares)		(796)
Repurchase of common stock, including excise tax	(160,323)				(160,323)
Purchase of subsidiary shares from noncontrolling interest	(1,358)						(1,358)
Other comprehensive income (loss)	55,011					55,011	0
Net income	73,482				73,482
Balance, end of period (in shares) at Mar. 31, 2025		56,626
Balance, end of period at Mar. 31, 2025	$ 3,643,216	$ 57		1,235,475	2,468,955	(61,853)	582
Balance, beginning of period (in shares) at Dec. 31, 2024	56,869	56,869
Balance, beginning of period at Dec. 31, 2024	$ 3,631,151	$ 57		1,190,222	2,555,796	(116,864)	1,940
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	390
Net income	$ 268,324
Balance, end of period (in shares) at Sep. 30, 2025	55,214	55,214
Balance, end of period at Sep. 30, 2025	$ 3,726,843	$ 55		1,329,512	2,384,297	12,397	582
Balance, beginning of period (in shares) at Mar. 31, 2025		56,626
Balance, beginning of period at Mar. 31, 2025	3,643,216	$ 57		1,235,475	2,468,955	(61,853)	582
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock units vested (in shares)			54
Equity withheld for employee taxes (in shares)		(16)
Equity withheld for employee taxes	(2,420)			(2,420)
Stock-based compensation expense	37,914			37,914
Exercise of stock options (in shares)		12
Exercise of stock options	891			891
Issuance of common stock from employee stock purchase plan (in shares)		107
Issuance of common stock from employee stock purchase plan	14,207			14,207
Repurchase of common stock, including excise tax (in shares)		(1,087)
Repurchase of common stock, including excise tax	(196,639)	$ (1)			(196,638)
Other comprehensive income (loss)	83,167					83,167
Net income	88,026				88,026
Balance, end of period (in shares) at Jun. 30, 2025		55,696
Balance, end of period at Jun. 30, 2025	3,668,362	$ 56		1,286,067	2,360,343	21,314	582
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock units vested (in shares)			10
Equity withheld for employee taxes (in shares)		(4)
Equity withheld for employee taxes	(665)			(665)
Stock-based compensation expense	43,651			43,651
Exercise of stock options (in shares)		5
Exercise of stock options	459			459
Repurchase of common stock, including excise tax (in shares)		(493)
Repurchase of common stock, including excise tax	(82,863)	$ (1)			(82,862)
Other comprehensive income (loss)	(8,917)					(8,917)
Net income	$ 106,816				106,816
Balance, end of period (in shares) at Sep. 30, 2025	55,214	55,214
Balance, end of period at Sep. 30, 2025	$ 3,726,843	$ 55		$ 1,329,512	$ 2,384,297	$ 12,397	$ 582